Mounjaro vs Ozempic — Which One Works Better?
- No. of episodes
- 4
- Latest episode
- 2026-04-07
Where can you listen?
The SURMOUNT-5 trial just settled the debate: tirzepatide delivered 47% more weight loss than semaglutide in the first major head-to-head study. Dr. Ben Synth analyzes the science behind dual-agonist therapy, dissects the real-world data, and explores what this means for patients choosing between these blockbuster medications.
For more content like this, visit QuietPlease.ai
This show includes AI-generated content.